Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
ID | DOID:3114 |
Name | serous cystadenocarcinoma |
Definition | A cystadenocarcinoma that derives_from epithelial cells originating in glandular tissue forming serous lesions. |
Source | DiseaseOntology.org |
Alt Ids | |
Path | disease disease of cellular proliferation cancer cell type cancer malignant adenoma malignant cystadenoma cystadenocarcinoma serous cystadenocarcinoma |
Path | disease disease of anatomical entity immune system disease autoimmune disease autoimmune disease of the nervous system malignant cystadenoma cystadenocarcinoma serous cystadenocarcinoma |
Molecular Profile | Therapy | Indication/Tumor Type | Response Type | Profile Response Detail |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT02834013 | Phase 0 | Ipilimumab + Nivolumab | Nivolumab and Ipilimumab in Treating Patients With Rare Tumors | Active, not recruiting | USA | 1 |